| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $205,375,056 ) (Continued on the next page) |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01FD005946 | University of Maryland Center of Excellence in Regulatory Science and Innovation | 000 | 8 | FDA | 1/9/2024 | $335,000 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS045585 | Role of microglial phagocytosis in prion diseases | 000 | 21 | NIH | 2/13/2024 | $617,991 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS127827 | Interoception and Pain: Noradrenergic Modulation of Nociceptive Transmission in the Parabrachial Nucleus | 000 | 2 | NIH | 3/27/2024 | $414,229 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI181601 | Escape by Shifting: Viral Entry Tropism Shift as an Evolutionary Mechanism of Immune Evasion | 000 | 1 | NIH | 2/7/2024 | $365,884 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS127827 | Interoception and Pain: Noradrenergic Modulation of Nociceptive Transmission in the Parabrachial Nucleus | 001 | 2 | NIH | 4/9/2024 | $32,217 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW012493 | Zambia Education Network for Implementation Science Training in Health (ZENITH) | 000 | 2 | NIH | 3/18/2024 | $245,116 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | D43TW012493 | Zambia Education Network for Implementation Science Training in Health (ZENITH) | 000 | 2 | NIH | 3/18/2024 | $50,000 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS129502 | Role of reactive astrocytes in prion diseases | 001 | 2 | NIH | 4/16/2024 | $43,578 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HS028984 | A Measure for Shared Decision Making in Maternity Care through Communicating CHOICes, CHildbirth Options, Information, and person-Centered Explanation | 000 | 2 | AHRQ | 5/29/2024 | $383,763 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25TW011804 | Strengthening Capacity in Health Research Ethics and Methodology in The Gambia | 000 | 3 | NIH | 3/23/2024 | $232,681 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH129343 | Multi-scale consequences of variants in the schizophrenia risk gene SETD1A in a population isolate. | 000 | 3 | NIH | 5/23/2024 | $386,250 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | A2230954 | Nurse Anesthetist Traineeships | 00 | 8 | HRSA | 5/24/2024 | $47,912 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01GM145806 | Molecular Physiology of Mitochondrial Calcium Uniporter | 000 | 2 | NIH | 4/19/2024 | $305,910 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01GM145806 | Molecular Physiology of Mitochondrial Calcium Uniporter | 001 | 2 | NIH | 6/10/2024 | $33,990 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI167367 | Mechanisms of protection against shigellosis in children | 000 | 3 | NIH | 5/16/2024 | $764,815 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01NS129502 | Role of reactive astrocytes in prion diseases | 000 | 2 | NIH | 11/9/2023 | $560,291 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM140822 | Extracellular miRNAs, innate immunity, and critical illness | 001 | 4 | NIH | 8/6/2024 | $38,625 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K23EY032525 | Identification of Anterior Segment Structural Biomarkers in Glaucoma Following Pediatric Cataract Using Ultrasound Biomicroscopy | 000 | 3 | NIH | 7/3/2024 | $236,357 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R03AG084940 | Role of mitochondrial Complex I deficiency in Alzheimer disease and dementia | 000 | 1 | NIH | 9/6/2024 | $311,000 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R35GM140822 | Extracellular miRNAs, innate immunity, and critical illness | 000 | 4 | NIH | 2/5/2024 | $347,625 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | P01MH139228 | Harnessing a Two-State FEP LHS to Optimize Engagement and Prevent Disengagement in CSC | 000 | 1 | NIH | 9/10/2024 | $1,706,223 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01CA284082 | Time-restricted eating to address cancer-related fatigue among survivors of hematological malignancies | 000 | 1 | NIH | 9/6/2024 | $376,294 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AG085492 | Understanding dynamics of brain network in TDP-43 related neurodegeneration | 000 | 1 | NIH | 9/9/2024 | $238,968 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | T3442149 | Primary Care Training and Enhancement-Community Prevention and Maternal Health | 00 | 4 | HRSA | 5/24/2024 | $473,993 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R25AI175011 | Integrated Training Program in Vaccinology (ITP-Vax) | 000 | 1 | NIH | 8/15/2024 | $352,643 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH121102 | Translational assessment of brain bioenergetic function in schizophrenia | 000 | 5 | NIH | 10/30/2023 | $633,965 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01ES033301 | Impact of Cadmium Exposure on Transporter Function and Drug Disposition in the Kidney | 000 | 3 | NIH | 3/29/2024 | $363,710 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | UG4LM013724 | Network of the National Library of Medicine Region 1 | 000 | 4 | NIH | 4/12/2024 | $1,885,658 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01MH121102 | Translational assessment of brain bioenergetic function in schizophrenia | 001 | 5 | NIH | 6/3/2024 | $70,441 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30AI174890 | Characterization of HIV-1 Genome Dimerization: A Strain Specific Dimerization Mechanism | 000 | 2 | NIH | 3/14/2024 | $52,694 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI179493 | Projecting the age shift in HIV prevalence in sub-Saharan Africa: a necessary epidemiologic step to prepare for the silver tsunami | 000 | 2 | NIH | 7/12/2024 | $213,886 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI179493 | Projecting the age shift in HIV prevalence in sub-Saharan Africa: a necessary epidemiologic step to prepare for the silver tsunami | 001 | 2 | NIH | 8/1/2024 | -$213,886 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R21AI179493 | Projecting the age shift in HIV prevalence in sub-Saharan Africa: a necessary epidemiologic step to prepare for the silver tsunami | 001 | 2 | NIH | 8/1/2024 | $213,886 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | K01MH134741 | Dissecting the causal impact of prenatal HIV exposure and the postnatal environment on development in Malawian Infants | 000 | 2 | NIH | 6/14/2024 | $155,943 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | F30AI174890 | Characterization of HIV-1 Genome Dimerization: A Strain Specific Dimerization Mechanism | 001 | 2 | NIH | 5/8/2024 | $1,280 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL166402 | Targeting a Defined Surgical Stress-Induced Inflammatory Pathway to Improve Peri-Operative Outcomes | 001 | 2 | NIH | 6/8/2024 | $44,794 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DK136529 | Clinical and Nutrigenetic Assessment of Zinc in Patients with Prediabetes | 000 | 2 | NIH | 6/11/2024 | $732,803 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U54CA273956 | Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center | 001 | 3 | NIH | 8/16/2024 | $1,428,096 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DE029946 | Disruption of Homeostatic Neuroimmune Interactions in Descending Circuitry in the Development of Pain Chronicity | 000 | 5 | NIH | 7/9/2024 | $586,709 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AR083363 | Lipid metabolism in the growth plate | 000 | 1 | NIH | 1/10/2024 | $535,718 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DK136529 | Clinical and Nutrigenetic Assessment of Zinc in Patients with Prediabetes | 001 | 2 | NIH | 6/12/2024 | -$381,668 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01HL129138 | Mechanisms Governing the Estrogenic Modulation of Sleep | 000 | 8 | NIH | 8/1/2024 | $586,618 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DK136529 | Clinical and Nutrigenetic Assessment of Zinc in Patients with Prediabetes | 001 | 2 | NIH | 6/12/2024 | $381,668 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01DK068491 | Surgical Studies of Gut Permeability | 000 | 18 | NIH | 7/29/2024 | $537,195 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | M0131364 | Behavioral Health Workforce Education and Training (BHWET) Program | 00 | 8 | HRSA | 6/18/2024 | $479,972 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | R01AI165510 | Serine/threonine kinase signaling in beta-lactam resistance of Staphylococcus aureus | 000 | 2 | NIH | 8/2/2024 | $669,744 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01FD005946 | University of Maryland Center of Excellence in Regulatory Science and Innovation | 011 | 8 | FDA | 4/29/2024 | $441,414 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01FD005946 | University of Maryland Center of Excellence in Regulatory Science and Innovation | 007 | 8 | FDA | 4/29/2024 | $2,002,798 |
| | 2024 | 2024 | UNIVERSITY OF MARYLAND, BALTIMORE | 220 ARCH ST OFC LEVEL2 | BALTIMORE | MD | 21201-1531 | BALTIMORE CITY | USA | U01FD005946 | University of Maryland Center of Excellence in Regulatory Science and Innovation | 017 | 8 | FDA | 6/24/2024 | $100,000 |
|
